FILLY 发表于 2025-3-23 10:26:43

Submitted on: 23 April 2010.
Revised on: 15 August 2010.
Accepted on: 01 October 2010.

___________________JOURNAL OF ENDOVASCULAR THERAPY

concubine 发表于 2025-3-23 16:02:54

http://reply.papertrans.cn/2/166/16556/16556-12.png

包庇 发表于 2025-3-23 20:57:27

Submitted on: 17 January 2000.
Revised on: 05 March 2000.
Accepted on: 30 April 2000.

___________________JOURNAL OF ENDOVASCULAR THERAPY

我不重要 发表于 2025-3-23 22:55:46

Submitted on: 27 March 2012.
Revised on: 14 June 2012.
Accepted on: 30 June 2012.

___________________JOURNAL OF ENDOVASCULAR THERAPY

CRATE 发表于 2025-3-24 05:14:16

Submitted on: 22 December 2003.
Revised on: 29 January 2004.
Accepted on: 12 March 2004.

___________________JOURNAL OF ENDOVASCULAR THERAPY

Lymphocyte 发表于 2025-3-24 07:39:40

http://reply.papertrans.cn/2/166/16556/16556-16.png

人造 发表于 2025-3-24 12:00:43

http://reply.papertrans.cn/2/166/16556/16556-17.png

WAIL 发表于 2025-3-24 16:56:40

http://reply.papertrans.cn/2/166/16556/16556-18.png

危机 发表于 2025-3-24 19:07:10

Submitted on: 12 October 2008.
Revised on: 18 January 2009.
Accepted on: 09 February 2009.

___________________JOURNAL OF ENDOVASCULAR THERAPY

duplicate 发表于 2025-3-25 01:20:42

http://reply.papertrans.cn/2/166/16556/16556-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊JOURNAL OF ENDOVASCULAR THERAPY 2024/2025影响因子:1.739 (J ENDOVASC THER) (1526-6028). (PERIPHERAL VASCULAR DISEASE)(